Myometrial oxidative stress drives MED12 mutations in leiomyoma
{{output}}
Background: More than 70% of leiomyomas (LM) harbor MED12 mutations, primarily in exon 2 at c.130-131(GG). The cause of MED12 mutations in myometrial cells remains largely unknown. We hypothesized that increased ROS promotes MED1... ...
